Mad1p, a phosphoprotein component of the spindle assembly checkpoint in budding yeast by unknown
Madlp, a Phosphoprotein Component of the 
Spindle Assembly Checkpoint in Budding Yeast 
Kevin G. Hardwick and Andrew W. Murray 
Department of Physiology, University of California, San Francisco, California 94143-0444 
Abstract. The spindle assembly checkpoint prevents 
cells from initiating anaphase until the spindle has been 
fully assembled. We previously isolated mitotic arrest 
deficient (mad) mutants that inactivate this checkpoint 
and thus increase the sensitivity of ceils to benomyl, a 
drug that interferes with mitotic spindle assembly by 
depolymerizing microtubules. We have cloned the 
MAD1 gene and show that when it is disrupted yeast 
cells have the same phenotype as the previously iso- 
lated mad! mutants: they fail to delay the metaphase to 
anaphase transition in response to microtubule depoly- 
merization. 
MAD1 is predicted to encode a 90-kD coiled-coil 
protein. Anti-Madlp antibodies give a novel punctate 
nuclear staining pattern and cell fractionation reveals 
that the bulk of Madlp is soluble. Madlp becomes hy- 
perphosphorylated when wild-type ceils are arrested in 
mitosis by benomyl treatment, or by placing a cold sen- 
sitive tubulin mutant at the restrictive temperature. 
This modification does not occur in Gl-arrested cells 
treated with benomyl or in cells arrested in mitosis by 
defects in the mitotic cyclin proteolysis machinery, sug- 
gesting that Madlp hyperphosphorylation is a step in 
the activation of the spindle assembly checkpoint. 
Analysis of Madlp phosphorylation in other spindle as- 
sembly checkpoint mutants reveals that this response to 
microtubule-disrupting agents is defective in some 
(mad2, bubl, and bub3) but not all (mad3, bub2) mu- 
tant strains. We discuss the possible functions of Madlp 
at this cell cycle checkpoint. 
CURATE chromosome replication and segregation re- 
quire mechanisms that can detect errors in these 
processes and  initiate  two  responses:  repair  sys- 
tems that correct the errors, and delay mechanisms that 
prevent the cell cycle from proceeding while the repairs 
are in progress. The combined detection and delay systems 
are known as cell cycle checkpoints or feedback controls 
(reviewed in Hartwell and Weinert,  1989; Murray, 1994, 
1995). 
Genetic analyses in both budding and fission yeast have 
identified a number of genes that play a role in ensuring 
that  cells  complete  DNA  replication  and  repair  DNA 
damage before they enter mitosis (Weinert and Hartwell, 
1988; Enoch and Nurse, 1990; AI-Khodairy and Carr, 1992; 
Rowley et al., 1992; Enoch et al., 1992; Weinert et al., 1994; 
A1-Khodairy et al., 1994, 1995; Ford et al.,  1994).  For ex- 
ample, the RAD9 gene is required to arrest the cell cycle 
in response to DNA damage, but is not required for the 
process of DNA repair (Weinert and Hartwell, 1988). This 
cell cycle control is not essential for growth in the absence 
of DNA damage, but irradiated rad9 cells are unable to 
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delay their passage through mitosis in response to the dam- 
aged DNA and produce lethally damaged progeny. 
The mitotic arrest caused by microtubule polymeriza- 
tion inhibitors suggests the existence of a spindle assembly 
checkpoint that monitors the status of the spindle and reg- 
ulates the metaphase to anaphase transition. The ability of 
single improperly oriented chromosomes (Callan and Ja- 
cobs, 1957; Li and Nicklas, 1995; Rieder et al., 1994), par- 
tially defective centromeres (Spencer and Hieter, 1992), 
and excess centromeres (Futcher and Carbon, 1986; Wells, 
W., and A. W. Murray, unpublished results) to delay ana- 
phase  suggests  that this checkpoint can detect subtle  as 
welt as gross defects in the structure of the spindle. Mu- 
tants in the spindle assembly checkpoint have been identi- 
fied in budding  yeast. The bub  (budding uninhibited )y 
benzimidazole; Hoyt et al.,  1991) and mad (mitotic arr¢st 
deficient;  Li  and  Murray,  1991)  mutants  were  isolated 
from collections of mutants that failed to form colonies in 
the presence of low doses of benomyl, a microtubule poly- 
merization inhibitor. The mad mutants were distinguished 
from mutants that affected microtubule assembly by their 
inability to delay cell division in response to microtubule 
depolymerization. The divisions that take place in the ab- 
sence of a fully functional spindle lead to a high frequency 
of chromosome loss and cell death (Li and Murray, 1991). 
The spindle assembly checkpoint defined by the mad and 
© The Rockefeller University Press, 0021-9525/95/11/709/12  $2.00 
The Journal of Cell Biology, Volume 131, Number 3, November 1995 709-720  709 Table I. 
Yeast strains 
KH 34  a 
KH 35  ct 
KH 36  a/a 
KH 120  a 
BEN 24  a 
BEN 27  a 
BEN 79  a 
KH 123  a 
KH 131  a 
KH 132  a 
KH 125  a 
KH 40  a 
KH 127  a 
KH 128  a 
MAY 2072  a 
KH 161  a 
KH 162  a 
KH 152  a 
KH 146  a 
ura3-1, leu2,3-112, his3-11, trp  l- l , ade2-1, can l- l O0 
ura3-1, 1eu2,3-112, his3-11, trp t-1, ade2-1, can l-  l O0 
ura3-1/ura3-1, leu2,3-112/leu2,3-112, his3-11/his3-11, trp  l-1/trp l- l , ade2-1/ade2-1, can l- l OO/can  l- l O0 
mad1-1, his3, leu2, ura3-52 
mad1-1, his3, leu2, ura3-52, rad9A::LEU2 
mad1-2, his3, leu2, ura3-52, rad9A::LEU2 
mad1-3, his3, leu2, ura3-52, rad9A::LEU2 
madl~l.l::HlS3,  ura3-1, Ieu2,3-12, his3-11, trpl-1, ade2-1, canl-lO0 
madl A.2::URA3, ura3-1, 1eu2,3-112, his3-11, trpl-1,  ade2-1, canl-lO0 
mad2-1, ura3-1, 1eu2,3-112, his3-11, trpl-1,  ade2-1, canl-lO0 
mad3A::LEU2, ura3-1, leu2,3-112, his3-11, trpl-1,  ade2-1, canl-lO0 
cinl A::HIS3, ura3-1, leu2,3-112, his3-11, trpl-1,  ade2-1, canl-lO0 
bubl A::HIS3, ura3-1, leu2,3-112, his3-11, trpl-1,  ade2-1, canl-lO0 
bub2A::URA3, ura3-1, 1eu2,3-112, his3-11, trpl-l, ade2-1, canl-lO0 
bub3A::LEU2, ura3-52, 1eu2,3-112, his3-A200, lys2-801 
cdc15-2, ura3-1, 1eu2,3-112, his3-11, trpl-1 
cdc23, ura3-1, leu2,3-112, trpl-1,  ade2-1 
tub2-403, ura3-52, leu2,3-112, lys2-801 
ura3-52, leu2,3-112, trpl-1 
bub mutants is expected to consist of components that de- 
tect defects in spindle structure, and a signal transduction 
pathway that relays this information and ultimately inhib- 
its a target in the machinery that initiates sister chromatid 
separation and anaphase. In common with other cell cycle 
transitions a major regulator of the metaphase to anaphase 
transition is thought to be the kinase activity of Cdc28p- 
mitotic cyclin complexes  (for reviews see  Norbury  and 
Nurse, 1992; Morgan, 1995).  Experiments in frog egg ex- 
tracts and in yeast have shown that the ubiquitin-mediated 
proteolysis of mitotic cyclins and other proteins is required 
for sister chromatid separation and entry into the next cell 
cycle (Holloway et al., 1993; Surana et al., 1993). 
Little is known about the biochemical mechanism of the 
spindle  assembly  checkpoint.  Previous  work  has  shown 
that BUB1 encodes a protein kinase (Roberts et al., 1994) 
and  that  BUB2,  BUB3  (Hoyt et  al.,  1991),  and  MAD2 
(Chen, R-H., and A. W. Murray, unpublished results) en- 
code proteins with unknown biochemical functions. Here 
we report the cloning of the MAD1 gene and show that it 
encodes a novel nuclear phosphoprotein that is an essen- 
tial component of the spindle assembly checkpoint, but is 
not essential for growth under normal conditions. We find 
that  this  protein  is  hyper-phosphorylated  in  conditions 
that activate the spindle assembly checkpoint. The hyper- 
phosphorylation of Madlp is only seen in a subset of mad 
and  bub  mutants  allowing us  to provisionally order the 
function of the known BUB and MAD genes. 
Materials and Methods 
Yeast Strains and Media 
Table 1 lists the strains used in this work. The original madl mutants were 
isolated in the A364A background. All other strains are derivatives of 
W303,  except the bub3A  strain MAY 2072  (Hoyt et aI., 1991) and the 
tub2-403  (KH  152) and  corresponding  TUB2  control  (KH146)  strain 
which are $288C derived.  Media were prepared and genetic manipulations 
were performed as described (Sherman et al., 1974). Stock solutions of in- 
hibitors were: benomyl 30 mg/ml in DMSO (added to hot media to main- 
tain solubility),  hydroxyurea 200 mg/ml in water, and a-factor 10 mg/ml in 
DMSO. Microcolony assays were carried out as previously described (Li 
and Murray, 1991). 
Cloning of MAD1 
Earlier attempts to clone the MAD1 gene using centromeric and multi- 
copy libraries were unsuccessful, although we isolated a number of multi- 
copy suppressors that conferred benomyl resistance on a variety of mad 
mutants and a mutant (cinlA) with defects in microtubule polymerization 
(Stearns et al., 1990). These suppressors  included the transcription factors 
YAP1 (also named PAR1, SNQ3,  and PDR4) and CAD1  along with a 
novel member of the hsp70 family, whose sequence will be reported else- 
where.  The  two  transcription  factors  had  been  previously isolated  in 
multi-copy suppressor screens due to their ability to confer multi-drug re- 
sistance on yeast cells  (Moye-Rowley et al, 1989; Hussain and Lenard, 
1991; Schnell et al., 1992; Wu et al., 1993). 
Assuming that the MAD1 gene was not present, or was at best poorly 
represented, in the available  libraries,  we constructed a new YCP50-based 
genomic library.  We  prepared  genomic DNA  as  previously described 
(Philippsen et al.,  1991) from W303  strain KH 34,  carried out a partial 
Sau3A digest,  isolated 6-10-kb fragments, and ligated  them to BamHI cut 
and  phosphatase-treated YCP50  (Rose et  al.,  1987). This ligation  was 
transformed into Escherichia coli strain XL1-Blue MRF (Stratagene, La 
Jolla,  CA) and four pools of ~10,000 colonies each were used to isolate 
plasmid DNA. This library DNA was then used to transform the mad1-1 
strain KH 120. After two to three days of growth on uracil-free  plates the 
Ura  ÷ yeast transformants were scraped off,  diluted,  and  replated  onto 
YPD plates containing 10  Ixg/ml benomyl. Plasmid DNA was prepared 
(Ward and Kirschner, 1990) from benomyl-resistant colonies and individ- 
ual plasmid isolates were re-tested for their ability  to confer benomyl re- 
sistance to KH 120. One plasmid, pKH130, with a 6.2-kb  insert, had this 
property. A 3.2-kb HindlII-SalI fragment from this plasmid was sufficient 
to complement madl strains. This fragment contained unique XhoI and 
XbaI sites. When either the XhoI or the XbaI restriction site was filled in, 
the resulting clone no longer complemented the madl mutant, suggesting 
that these sites lay within, or near, the complementing gene. 
To check  that the  HindlII-Sall fragment contained the MAD1  gene 
rather than a suppressor we cloned the flanking HindlII fragment into the 
URA3-containing integration vector pRS306  (Sikorski and Hieter, 1989). 
This construct was cut with BgllI then transformed into the mad1, ura3 
strain, KH 120, to create a mad1 strain in which the genomic locus of the 
cloned gene was marked with URA3. This strain was then mated with KH 
35, a MAD1, ura3 strain, the resulting diploids  were sporulated and tet- 
fads were dissected.  In 10 tetrads the mad phenotype co-segregated with 
the  Ura  + spores, confirming that  the sequences in pKH130 are  closely 
linked to MAD1. 
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We sequenced the whole of the 3,188-bp HindIII-Sal! fragment, after sub- 
cloning various fragments into pBluescript and making ExoIII deletion se- 
ries (Henikoff, 1984).  We found a single large open reading frame that is 
predicted  to encode a  protein of 749 amino acids. The sequence of this 
reading frame was completed and confirmed on the second strand using 
specifically designed primers. 
The  MAD1  reading frame was used to  make a  digoxygenin-labeled 
probe with a DNA labeling kit (Boehringer-Mannheim Corp., Indianapo- 
lis, IN) following the manufacturers instructions. This was used to probe a 
set  of  filters  purchased  from  the  American  Type  Culture  Collection 
(Rockville, MD) that have DNA from lambda and cosmid clones covering 
over  96%  of the  genome of Saccharomyces  cerevisiae  cross-linked to 
them. The  MAD1  probe  specifically recognized a  single lambda clone 
(70269) thereby mapping it to the left arm of chromosome VII between 
RAD6 and CYH2. 
Two mad1 gene disruptions were made (see Fig. 1): one, madlA.1, re- 
places the HinclI fragments from nucleotides 994 to 2,186 with a BamHI 
fragment containing the HIS3 gene (pKH149). The other, madlA.2,  re- 
places almost the complete MAD1 reading frame from the BgllI site at 
position 76 to the XmnI site at 1911 with the URA3 marker (pKH160). 
These constructs were used to transform haploid and diploid strains (KH 
34, 35, and 36). Benomyl-sensitive haploid transformants were recovered 
and the gene disruptions confirmed using both PCR and Western blotting 
analyses (see Fig. 4). 
Preparation of  Antibodies against Madlp, 
Immunoblotting, and Immunofluorescence 
The BgllI fragment encoding residues 27 to 310 of Madlp was cloned into 
the BamHI site of pGEX3X (Smith and Johnson, 1988). This glutathione- 
S-transferase (GST) 1 fusion construct was transformed into E. coli strain 
HB101 and its expression induced with 0.1 mM IPTG for 3 h at room tem- 
perature. Cells were pelleted and resuspended on ice with PBS (140 mM 
Na2HPO4, 1.8 mM KH2PO4, 138 mM NaCI, 2.7 mM KCI, pH 7.2), repel- 
leted, and frozen in liquid nitrogen. The frozen cells were resuspended in 
five volumes of PBS containing i mM EDTA, i mM EGTA, i mM MgCI2, 
1 mM PMSF, 200 p.g/ml lysozyme, and 5 v.g/ml DNase. To complete their 
lysis the cells were sonicated briefly. KC1 was added to 0.25 M and DTT to 
15 mM and the lysate was spun at 35,000 rpm in a rotor (model 50.2 Ti; 
Beckman Instruments, Palo Alto, CA) for 1 h. The supernatant was then 
loaded onto a 10 ml glutathione agarose column (Sigma Chemical Co., St. 
Louis, MO) which was then washed with PBS containing 0.25 M KCI and 
0.5  mM DTr. The Madl-GST fusion protein was eluted with 5 mM re- 
duced glutathione in 50 mM Tris, pH 8.1, 0.25 M KC1. The peak fractions 
Were dialyzed extensively into 50 mM Hepes, pH 7.6, 50 mM KCI, 30% 
glycerol. This protein was sent to Berkeley Antibody Company (Berkeley, 
CA) where it was used to immunize a rabbit. The rabbit serum was passed 
over a 50 ml column of GST fusion protein coupled to Affigel I0 (Bio-Rad 
Labs, Hercules, CA) to remove anti-GST antibodies, then affinity purified 
using a 5 ml column of the Madlp-GST fusion protein coupled to Affi- 
gel 10. 
Yeast extracts for immunoblotting were made by bead-beating cells in 
SDS sample buffer (80 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 10 mM 
EDTA, 0.0013% Bromphenol blue, 50 mM NaF, 100 IxM NaVanadate, 1 
mM PMSF and LPC [10  ixg/ml  leupeptin, pepstatin, and chymostatin]). 
Standard methods were used for SDS-PAGE and protein transfer to ni- 
trocellulose (Harlow and Lane, 1988).  Blots were stained with Ponceau S 
to confirm transfer and equal protein  loading, then blocked for 30 min 
with blotto (4% dried milk, PBS, 0.1% Tween 20). The affinity-purified 
anti-Madlp antibody (0.5 mg/ml glycerol stock) was used at a dilution of 
1:5,000  in blotto,  and the anti-Clb2p antibody (1 mg/ml glycerol stock; 
kindly provided by Doug Kellogg, University of California, Santa Cruz, 
CA) at 1:1,500, either overnight at 4°C or for 2 h at room temperature. Af- 
ter washing extensively in PBS the blots were then incubated with HRP- 
conjugated anti-rabbit  antibodies (Amersham Corp.,  Buckinghamshire, 
UK) at a 1:5,000 dilution, washed again, and developed using Amersham 
ECL detection reagents following the manufacturer's instructions. 
The affinity-purified anti-Madlp antiserum still recognizes a  number 
of other proteins in addition to Madlp on immunoblots of whole yeast cell 
1. Abbreviations  used in this paper:  GST, glutathione-S-transferase; LPP, 
lambda protein phosphatase. 
extracts including a prominent band at 85 kD (see Fig. 4). However, these 
cross-reacting proteins are not immunoprecipitated by the antibody (see 
Fig. 9), nor are they recognized well in formaldehyde-fixed yeast cells (see 
Fig. 5), suggesting that they are unlikely to be closely related to Madlp. 
Attempts have been made to reduce the background on the immunoblots, 
by  using higher salt  concentrations and  other blocking agents such as 
BSA,  but  the  conditions  used  here  provide  the  optimal  detection  of 
Madlp and its hyperphosphorylated forms. 
For solubility studies, spheroplasts were prepared by treating logarith- 
mically growing cells (KH 34) with 100 mM Tris, pH 9.4, 10 mM DT'F for 
10 min at room temperature, and then digesting the cell wails with lyticase 
in YPD containing 0.7 M sorbitol and 10 mM Tris, pH 7.4, for 15 min at 
30°C.  Spheroplasts were washed and allowed  to  recover for 30 min at 
room temperature in YPD containing 0.7 M  sorbitol, washed in ice-cold 
lysis buffer (0.2 M sorbitol, 20 mM Hepes, pH 6.8, 50 mM KOAc, 2 mM 
EDTA, 0.5 mM EGTA, LPC, 1 mM PMSF), and then dounced 20 times. 
This homogenate was spun at 7,000 g in a Beckman TL100.3 rotor and the 
pellet resuspended in lysis buffer and dounced and spun once again to re- 
move any remaining whole cells and debris. DTT was added to 1 mM to 
the pooled supernatants, and aliquots were treated with the following: 1% 
Triton X-100, 1 M NaCI or 1% Triton X-100 with 1 M NaC1 and 0.25 rag/ 
ml DNase/RNase. After 60 min the extracts were spun at 50,000 rpm in a 
Beckman TL100.2 rotor for 30 min. The supernatant fractions were pre- 
cipitated  with TCA and equivalent fractions of pellet  and supernatant 
fractions separated by SDS-PAGE. 
For gel filtration, yeast extracts were made by bead-beating whole cells 
(KH 34) in 50 mM Hepes, pH 7.6, 25 mM KCI, 50 mM NaF, 1 mM MgC12, 
1 mM EGTA, 0.1% NaDeoxycholate, 10% glycerol, LPC, 1 mM PMSF, 
0.5 mM DTI'. The lysate was spun briefly to remove the glass beads and 
cell debris and then spun for 30 min at 55,000 rpm in a Beckman TL100.2 
rotor. 200 p.1 was loaded on to a Superose 6 HR 10/30 column (Pharmacia 
Biotech Inc., Piscataway, NJ) running at 0.3 ml/min and 0.5 ml fractions 
were collected. For sucrose-gradient centrifugation a bead-beaten extract 
was made in 50 mM Hepes, pH 7.6,  50 mM KC1, 50 mM NaF, 1 mM 
MgCI  2, 1 mM EGTA, 0.1% NaDeoxycholate, LPC, I mM PMSF, 0.5 mM 
DTT, and spun for 30 min at 55,000 rpm in a TL100.2 rotor. A  2 ml su- 
crose gradient (5--40%) was made using a  SG5  gradient mixer (Hoefer 
Scientific Instruments, San Francisco, CA), 100 p.l of extract was loaded 
on top, and spun in a TLS55 swinging-bucket rotor at 55,000 rpm for 14 h. 
75 l.d fractions were taken from the top of the gradient. The sucrose gradi- 
ent and the gel filtration  column were  calibrated with markers from a 
Pharmacia high molecular weight calibration kit. 
For  immunofluorescence, spheroplasts were prepared  as above then 
fixed with 3.7% formaldehyde for 5 to 30 min, gently sedimented, washed, 
and resuspended in 0.7 M sorbitol, 0.1 M  KPO4, pH 7.5, before being at- 
tached to poly-lysine--coated multi-well microscope slides. The slides were 
plunged into methanol (-20°C) for 5 min and acetone (-20°C) for 30 s, 
and then allowed to air dry. After washing with PBS, cells were blocked 
for 30 min with blotto, and then stained overnight at 4°C with primary an- 
tibody diluted (1:5,000  for anti-Madlp, 1:200 for anti-tubulin, 1:1,000 for 
anti-Raplp,  1:2,000  for mAb 414) in blotto.  Ceils were washed several 
times with blotto and then incubated for 1 h at room temperature with a 
1:50 dilution of FITC or rhodamine-labeled anti-rabbit, mouse or rat sec- 
ondary antibodies from Cappel (Organon Teknika Corp., Durham, NC). 
After washing with blotto and then PBS, the DNA was stained with 1 Ixg/ 
ml DAPI in PBS and cells were mounted in 90% glycerol, 1 mg/ml phe- 
nylenediamine, pH 9.0. Coverslips were sealed with clear nail polish and 
slides stored at -20°C. 
Phosphate Labeling and Phosphatase Digestion 
Cells  were  grown  overnight  in  low-phosphate  YPD  medium  (Rubin, 
1975), diluted into fresh medium and grown to log phase. 1 mCi [32p]or- 
thophosphate (Amersham Corp.) was added to 5 ml cultures which were 
shaken at room temperature for one hour. Cells were pelleted, washed, 
and resuspended on ice in RIPA buffer (50 mM Hepes, pH 7.6,  150 mM 
NaC1,  1% Triton-X 100,  1% NaDeoxycholate, 0.1%  SDS, 1 mM PMSF, 
LPC, 1 mM DTT, 50 mM NaF, 1 mM NaVanadate). An equal volume of 
glass beads was added and the cells were bead-beaten for 2 min at 4°C. 
Extracts were clarified, diluted to 1 ml with RIPA buffer and then 1 i~1 of 
anti-Madlp antibody and 10 ILl of protein A-Sepharose 6MB (Pharmacia) 
beads were added and incubated overnight at 4°C. Immunoprecipitates 
were washed several times with RIPA buffer, twice with PBS and once 
again with RIPA before heating the beads in sample buffer and separating 
the sample by SDS-PAGE. Gels were stained, fixed, dried down, and ex- 
posed to film overnight at -80°C. 
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were made by bead-beating  yeast cells for 2 min in lysis buffer (50 mM 
Hepes, pH 7.6, 75 mM KCI, 1 mM MgCI~, 1 mM EGTA, 0.1% NP40,  1 
mM PMSF, LPC, 50 mM NaF, I mM NaVanadate) and DTI" was added to 
1 mM  after  clarification.  Madlp was immunoprecipitated  as described 
above  and  the  immunoprecipitate  was washed  three  times  with  lysis 
buffer, twice with PBS and then with LPP reaction buffer (50 mM Tris, pH 
8.0, 2 mM MnC12, 1 mM PMSF, LPC, 1 mg/ml acetylated  BSA). 20 U of 
lambda protein  phosphatase  (New England  Biolabs Inc., Beverly,  MA) 
were  added  to the Madlp immunoprecipitate  in 50  txl of LPP reaction 
buffer and incubated  for 30 min at 30°C. Phosphatase  inhibitors were 2 
mM ZnCI2, 1 mM NaVanadate and 50 mM NaF.  The Sepharose  beads 
were then spun down and heated in sample buffer before  separating the 
sample by SDS-PAGE and analyzing Madlp by immunoblotting. 
Results 
MAD1  Is Predicted to  Encode a Novel 
Coiled-Coil Protein 
We cloned the wild-type MAD1  gene by complementing 
the benomyl sensitivity of the madl-1  mutant. The com- 
plementing plasmid rescued all three madl alleles, did not 
rescue other benomyl sensitive mutants, and contained a 
DNA  fragment  that is closely linked to the MAD1  gene 
(see  Materials  and  Methods).  Sequencing  the  minimal 
complementing DNA fragment revealed a 2,250-bp read- 
ing frame which spans both an XhoI site and an XbaI site. 
Filling in either the XhoI site or the XbaI site destroyed 
the  ability  of  this  fragment  to  complement  madl.  Two 
gene disruptions were  made, one replacing the 3'  half of 
the MAD1 gene with HIS3 and a second that replaced al- 
most  the whole reading frame  with the  URA3 gene  (see 
Fig. 1 and Materials and Methods). These constructs were 
used to transform haploid and diploid yeast strains.  The 
disrupted haploid strains grow as well as wild-type cells at 
all temperatures  tested,  are sensitive  to anti-microtubule 
drugs  (see  Fig.  3  a),  and are  unable to complement  the 
madl  alleles  previously isolated  confirming  that the dis- 
rupted reading frame is indeed MAD1. 
The DNA sequence and predicted translation of MAD1 
lkb 
SalI  XhoI  Xba[  HindIH  HindUI 
YCP50 
I  MAD1  ~  "... 
b.  I  ""  ORF 
C,  madlA.1 
HIS3 
d .  mad  I  d,2 
URA3 
Figure 1.  Restriction  map of the MAD1 clone and gene disrup- 
tions. (a) Restriction  map of the MAD1 clone isolated from the 
YCP50  library showing the position  of the open  reading frame 
(ORF). Vector  sequences  are indicated by the thicker line.  (b) 
Restriction  map of the open reading frame (ORF).  (c) The bar 
marks the HinclI fragments that were  replaced  with the HIS3 
gene to create madlA.1.  (d) The bar marks the BgllI-XmnI frag- 
ment that was replaced with the URA3 gene to create madld.2. 
is shown in Fig. 2 a.  The amino acid sequence of Madlp 
shows about 20%  identity to a large  number of proteins 
that contain or are predicted to contain regions of coiled- 
coil  (e.g.,  myosin,  integrins,  NuMA  [Yang  et  al.,  1992], 
CENP-E [Yen et al., 1992], Usolp [Nakajima et al., 1991]). 
This homology is mainly due to the presence of heptad re- 
peats of hydrophobic residues,  which are found through- 
out the MAD1  reading frame.  Using the GCG computer 
program PEPCOIL we found that the bulk of Madlp does 
a  -~14  TTATTTTAGTCTCTTATT~ATCGCTA~GGAGCAATGA~TTGATAGCGmGTTACCCTAGGAATAAT~CC7AACAATT7TTTCCATC$T 
-24  A~ATCGAGAGG~AATAGTA~T~TGGATGTGAGAGCGGCATTGCAATGTTTCTTCAGTGCAT~rGAG~GGACGAT~CACTGG~A 
MU  RAALQCFFSALSGR  7GKK 
~7  TTGGGACTAGAGATC~ATTCTATCCAGTAC~GAGC~TAGTGGTGGGTCCT~CCT~TCT~GGAAAG~CTGGAGG~TCGCCCGAC 
23LGLEI¥SIQy  MSNSGGSSP  LESPGGSpD 
157 GTAGGCAGTACA~TGGACA~GT~TCGTCAGATTCAGGCGTTACAATTCAAGCTC~TACTCTACAAAATGAGTATGAGA~TGA~A 
53VGSTNGQSNR  IQALQFKLN  LQNE  EIZ~ 
247 TTG~AG~TACA~`r~CAGAC~AATATC~TAGAAAAGAAATAT~GGCCACGA~TGACGAATTAGAGAAAGCATTG~TGATACA~ATAT 
83LQLQKQTNIL  KKYKATIDE  EKAL  DTKY 
337CTTTATG~GCAATGATAAATTGGAGC~GAGTT~GAGTTTG~AG~AGATCAGCTAATTCG~G~TGATA~GAC~ATGCATA 
II3LYESNDKLEQ  LKSLKERSA  SMND  DKCI 
427GAGG~TTGCG~CAA~CCTCC~CAAAGATT~AGAAATG~AGACTTTAAGGCAGCAGTATGAT~CG~GTTATCAAAGGTCACT~C 
143EELRTTLQNK  LEMETLRQQ  DSKL  KVTN 
5l7C~TGTGACCATTTCAAGTTGGAAGCAGAGAGCT~TCATTCGCTACTGATG~ATATGAGAAA~A~7~AGAGGCAAAGTGTGGATATC 
173QCOHFKLEAESSHSLLMKYE  Z:KR  $VDI 
607 ~GATTTG~AGCATC~G~GATGG~AGGATGATG~TTATCTTCGGT~AAGcATC~AAGATGATAAACTCACATC~AAACTACTCC 
203KD  QNOVMEKDDEL$SVKAS  MIN$  pNyS 
697  AC~G~GAGTT~AAC~AG~TC~CTGAAATGAA~aAA~GATC~AA~A~CAAn~TCAGTATACTAAAsAAT~GGAAC~AGCG~cATGCAA 
233~E  ~NELTEMNKMIQOQVQy  MELELANMQ 
787 CAA~CC~TG~TTGAAAAAACTT~AACA~TCCCAGGACACTTCTACTTqTTGGAAATTAGAAAATGAAAAACTACAAkaCA~TTAAGT 
263QA  ELKKLKQSQDTSTFW~  ~KLQNKLS 
877 CAATTACACGTACTCGAAAGTCAATA~GAAAA~TTCA~TTGGAAAACATAGATCTAAAATCZAAATTA~CCAAATGGGAAATTTATAAT 
283QL  VLESQYEN  QLENIDL~SMLTKWEIyN 
96~ GATA~TGACGATGATGA~GAT~C~TGTTAAC~C~TGAT~T~AATAATAATAAAAATGATAATAATAATGATAATAAT~TGAT 
323DS  DDOONNVNNN~NNNNN~Nn.NNnNNND 
~57AC~GTAAT~C~CAA~ATqAA~TAACAACAGAACC~A~T~CATAAGAAA~AAC~T&AAGAGATTATCCGGGACTGGAAACTT 
353TS  NNN~NNN  N  THHNI~NNPE~:IRDWRL 
1147 ACCAAAAAGG~TGTTTAATTTTGACAGATATG~TGATAAGTTA~GATTGGACAATAACAATTTAAAGCTACTGAATGATGAAATGGCT 
383TK  ECLILTDM  DKL  LDNNNLKLLNOEMA 
1237 TTAGAGAGAAACC~ATACTAGATTTGAAC~GAATTATGAAAACAAC~AGTAAATTTGAAAAGATTAAATCACGAGTTAG~CAACAG 
413LERNQILDLNK  yEN  IVNLK~LNHELEQ~ 
1327 ~GAGTTTATCTTTcc~GAATGT~GATTACTG~GCG~CAATTA~ATG~CC~A~AT~CCGCACAAA~TAATGCTTTACTAGAGGTCGAA 
443KSLSFEE  RLL  EQL  GL¥SAONNALLEVE 
1417 ~TAGTGA~CACATG~TCAAACAAGAACGTAAACG~GATATGAATAATTTGATCGATA~TATA~AAAThAGACAG~GATTTAACA 
473NSETNA5  KNV  EDM  NLIDT~NKTE~LT 
~5~7~C~AACT~`AA~CTA~GATCAGTTATTATC~ATTCCAATGATGTAGAAACACAAA~AAAAA~GAGGAAGTTGACAAGTGACCAA 
503NEL  ~  LN  QLL  NSN  VETQRKKRKLTSDQ 
1597 ATTG~TTT~TTATTCACAGAGGCTCAACGAATTGCAACTGGA~ATG~AAG~GTCTCGAGGnAGT~AGTAAAG~ACa~ACTAC~ATT 
5331GLMYSQ  LNELQLZ  VSVSRELSKAQTTI 
168~ CAGCTACTACAAGAAAAATTAGAA~G~TAACN&A~CTA~GGAGAAAAAAATACGTATACT~CAAT~ACGTGACGGCCCCTTCATAAAA 
5fi3QLLQEKL  ELTKLKE  KIRIL~LROGPFIK 
~777GATC~TTTATC~G~CA~TT~C~TCTTCTAGAAAAGGAAAA~GCAGATTTACTTAACGAATTGAAAAAGAATAATCCAGCAGTG 
593DQFIKKN  LLILEKE  ADLLNELKKNNPAV 
1867 G~CAGTACCCATT~CTGTTTATGA~cACTAAATTTCGAGTTGAAA~AGTTCGAACAGGAAGT~zTxAAGTCAAATAAAAGATTTTCC 
623ETVPlSV  DSLNFEL  QFEQEVFKSNK~FS 
1957AGACT~GC~GTTTT~AATAATAAATcTTTGGAGTTTATTGACGTTGTAAACTCATTA~TAGGTTTTAAA~TGG~TTTCAACAAGA7 
653RLKQVFN  KSLEFIDVVNSLLGFKLEFQQD 
2047 AGTCGTGTG~TATTTTCCTGTTTCAAACCTGAAAAATATTTGATTGCTGATCTAAATCAAAA~ACTTTGAAATCTAACCTTGATGCA 
683$NVKI~SCFKpEKYLIA~LNEN~LKSNLDA 
213V GATATAG~GGAT~GGATGKTCTCATGAATCTATGGGTGGAAGATAGAGsTCAAC~TCCG7~CT~T~GGCAACAATAACATTGCGTCTG 
713DIEGWDDLMNLWVED~GQL?~FLATITLRL 
2227  TGGGAACAGCGACAAGCCAAATAAGTGTATATACATTTC~AATAGATAATAGTAATCGGTTTTATAA~A7GATAAA~T~CT~TCCGCTGA 
743WEQRQAK" 
2317 CAT~TTGTT~GTCACAAAATT~TTTTATCTTTCTTCATCATTGA~CT~TTATGATTCCTTT~TATGCAAAAA~AAA~ATTGTGTTG 
2407  ~G~TAAAAACA~TTAC&GAA~AAGT~ACACATGATATAAA~GAAGCCCAGTTTTTCATAGCTATTAA~GGG~ATAAATGCACTTA 
2497  TATGA~G~GGTGATTCTAA~TCA~TCTG~GGATsTTGCTGTCCTCTCCATCA~CC~TAC~GGT~CG~CTTAACATTGATCTA 
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Figure 2.  (a) Nucleotide sequence and translation of the MAD1 
gene. An unusual stretch of asparagine residues and the putative 
bi-partite  nuclear  localization  signal  are  underlined.  This  se- 
quence is available from Genbank/EMBL/DDBJ under accession 
number  U14632.  (b)  Coiled-coil  prediction  for  Madlp.  This 
GCG  PEPCOIL  prediction  uses  the  algorithm  of Lupas et  al. 
(1991) with a window of 28 residues. 
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Fig. 2 b) (Lupas et al., 1991).  The sequence of Madlp also 
contains  a  putative  bi-partite  nuclear  localization  se- 
quence  (residues  506-527)  (Dingwall  and  Laskey, 1991), 
many  potential  phosphorylation  sites  and  an  unusual 
stretch rich in asparagine residues (residues 330-372). 
The MAD1 Gene Encodes a Component of the Spindle 
Assembly Checkpoint 
We studied madlA strains for defects in the spindle assem- 
bly  checkpoint.  The  benomyl  sensitivity  of the  original 
mad mutants could be rescued with hydroxyurea, a  drug 
that lengthens S phase (Li and Murray, 1991).  Since bud- 
ding yeast can assemble a spindle during S phase, our in- 
terpretation of this  result is that the  enforced delay in  S 
phase allows mad cells enough time to correctly assemble 
b 
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Figure 3.  Benomyl sensitivity  of the madlA.1 strain (KH 123). 
(a) Yeast cells (KH 34, KH 123, KH 132, and KH 40) were spot- 
ted onto YPD plates containing  the indicated  concentrations of 
benomyl and hydroxyurea and were photographed after 3 d of 
growth at 23°C. (b) Microcolony  analysis of the growth  of yeast 
cells (KH 34, KH 123, and KH 40) on YPD plates containing  12 
ixg/ml benomyl at 23°C. Data was collected from at least 60 cells 
of each genotype. 
their mitotic spindle before initiating anaphase. Although 
1 mg/ml hydroxyurea slightly decreases the benomyl sensi- 
tivity of wild-type  cells,  it  does  not  rescue  the  benomyl 
sensitivity  of mutants  with  defects  in  microtubule  poly- 
merization, such as cinlA (Fig. 3 a), even at lower concen- 
trations of benomyl (data not shown). Fig. 3 a  shows that 
the  madlA.1  deletion  mutant  behaves  like  the  original 
madl and mad2-1 alleles: at 23°C it is sensitive to benomyl 
at concentrations  of 7.5  ixg/ml  and  above, and  this  ben- 
omyl sensitivity can be rescued by i  mg/ml hydroxyurea. 
We used microcolony assays to monitor the initial rate 
of cell division of madlA.1 strains on benomyl-containing 
medium.  Individual,  unbudded  cells  were  picked  with  a 
dissecting needle and their growth on plates containing 12 
Ixg/ml benomyl was analyzed over a period of 8 hours. Fig. 
3 b shows that, like the original madl alleles, the madla.1 
strain  initially  divided  faster  than  the  wild-type  control 
cells.  This  behavior  of  madla.1  differs  radically  from 
strains with defects in microtubule polymerization, which 
are unable to divide in the presence of benomyl and arrest 
as  large  budded  cells.  This  result  is  consistent  with 
madlA.1 cells being unable to sense or respond to the dis- 
ruption of their microtubules and thus initiating anaphase 
before  spindle  assembly  is  complete.  It  has  previously 
been shown that mad mutants fail to maintain the mitotic 
activity of Cdc28p (monitored as histone H1 kinase activ- 
ity) when they are treated with benomyl (Li and Murray, 
1991).  We have confirmed this result with madlA.1  (data 
not shown). 
Madlp Is a Soluble Nuclear Protein 
To analyze the properties of Madlp we raised polyctonal 
antibodies,  against  a  GST fusion  protein  that  contained 
Figure  4.  Immunoblots of yeast  extracts with  anti-Madlp.  (a) 
Whole cell extracts made from madlA.1 cells (KH 123), wild-type 
cells (KH 34) or wild-type cells containing  the MAD1 gene on a 
centromeric (pKH130)  or two-micron  (pKH137)  plasmid  were 
immunoblotted with affinity-purified  anti-Madlp antibodies.  (b) 
Whole cell extracts made from wild-type (KH 34), the three orig- 
inal mad1 alleles (BEN 24, 27, and 76), or the two mad1 deletion 
strains constructed  (KH 123, KH 131), were immunoblotted with 
affinity-purified  anti-Madlp  antibodies.  The  truncated  protein 
expressed in madlzl.1 is indicated  (*). 
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purified and used to probe Western blots of whole cell ex- 
tracts from a number of yeast strains. Fig. 4 a shows that a 
protein of 90 kD that is seen in the wild-type cell extract is 
absent from the madlzll  strain, and present at higher lev- 
els  in  strains  containing  MAD1  plasmids.  A  truncated 
Madl protein is expressed in madlA.1  where the 3' end of 
the MAD1  gene has been removed, and in two of the three 
previously isolated mad1  alleles (Fig. 4 b). The latter find- 
ing  provides strong  evidence  that  the  reading  frame we 
have identified is indeed the MAD1  gene and that the an- 
tiserum efficiently recognizes both wild-type and  a  num- 
ber of mutant  Madl  proteins.  The affinity-purified anti- 
Madlp antiserum still recognizes a  number of other pro- 
teins in addition to Madlp on immunoblots of whole yeast 
cell extracts, including a prominent band at 85 kD. How- 
ever, the  cross-reacting proteins  are  not  immunoprecipi- 
tated by the antibody (see Fig. 9), nor are they recognized 
well in formaldehyde-fixed yeast cells (Fig. 5), suggesting 
that they are unlikely to be closely related to Madlp. 
Immunofluorescence with affinity-purified anti-Madlp 
antibodies was used to localize Madlp within yeast cells. 
Fig. 5 reveals that the bulk of Madlp appears as discrete 
patches in the nucleus. The reactivity of Madlp is sensitive 
to fixation. We found that greater than 5 min of formalde- 
hyde  fixation  dramatically  reduced  Madlp  staining  and 
further fixation completely abolished it (data not shown). 
We used a number of antibodies to confirm that the struc- 
ture  of the  yeast nucleus  was relatively intact  after fixa- 
tion. Fig. 5 (e-j) shows that antibodies to tubulin (Adams 
and  Pringle,  1984)  and  to  the  90-kD  component  of the 
spindle-pole  body  (Rout  and  Kilmartin,  1990)  gave the 
previously reported patterns, and that there was no consis- 
tent co-localization of these proteins with Madlp. In addi- 
tion, we found no co-localization of Madlp with Raplp (a 
telomere protein; Klein et al., 1992) or nuclear pore anti- 
gens (data not shown). Although we observed coincident 
localization  of some  of the  Madlp  staining  and  spindle 
pole bodies in a few cells, we conclude that Madlp has a 
novel nuclear localization pattern. 
Since some coiled-coil proteins form large insoluble oli- 
gomeric structures (Fuchs, 1994) we tested the solubility of 
Madlp.  Yeast  extracts were  made  by preparing  sphero- 
plasts, douncing them and then extracting the homogenate 
with buffers containing  various salts, detergents  and  nu- 
cleases. The extracts were then spun at 100,000  g to sepa- 
rate soluble from insoluble material. Pellet and superna- 
tant fractions were then run on SDS gels and blotted for 
Madlp  (Fig.  6).  Under  all conditions  the bulk of Madlp 
was found in the supernatant, but we reproducibly found 
that a minor fraction pelleted. However, even this fraction 
could be solubilized by a combined treatment with 1% Tri- 
ton/1 M NaC1/DNase and RNase, suggesting that Madlp is 
unlikely to be a constituent of the nuclear scaffold (Mirza- 
yan et al., 1992). 
Another striking characteristic of coiled-coil proteins is 
Figure 6.  Madlp  solubility,  sizing and sedimentation analyses. 
(a) The bulk of Madlp behaves as a 'soluble protein. Yeast cells 
(KH 34) were spheroplasted and homogenized.  Aliquots of this 
homogenate were then extracted with either 1% Triton X-100, 
1 M NaC1 or a combination of 1% Triton, 1 M NaC1, 0.25 mg/ml 
DNase and RNase, before being spun  at 100,000 g for 30 min. 
Pellet and supernatant fractions were immunoblotted with affin- 
ity-purified  anti-Madlp  antibodies.  Yeast  extracts were  made 
from wild-type (KH 34) cells by bead-beating, spun at 100,000 g 
for 30 min, and then (b) loaded over a Superose 6 gel filtration 
column,  or (c) fractionated by centrifugation  through a 5-40% 
sucrose gradient. Fractions were immunoblotted with affinity-puri- 
fied anti-Madlp antibodies.  Madlp is the uppermost band in b 
and c and the molecular masses of marker proteins are indicated. 
their rod shape. To assess the hydrodynamic behavior of 
Madlp we fractionated yeast extracts by gel filtration and 
sucrose gradient sedimentation. Fig. 6 b shows that Madlp 
behaves as a  very large protein on gel filtration, running 
ahead of the 670-kD thyroglobulin marker. A  similar size 
for Madlp was obtained by immunoblotting yeast extracts 
that had been separated in their native state by gradient 
gel  electrophoresis  (not  shown).  However,  Madlp  sedi- 
ments relatively slowly through sucrose gradients, peaking 
in the same fraction as the 4.4  S BSA marker (Fig. 6 c). 
Neither the sedimentation nor the gel filtration behavior 
of Madlp was altered by the presence of 1 M  NaC1 (not 
shown).  Similar fractionation behavior has been reported 
Figure 5.  Immunofluorescent staining of yeast cells with anti-Madlp. Wild-type (a and b) (KH 34) and madlA.1 (c and d) (KH 123] cells 
were stained  with affinity-purified  anti-Madlp antibodies  (b and d) and DAPI (a and c). Patchy nuclear staining is observed in wild- 
type cells and is absent in the madlA.1  cells. Wild-type diploid cells (KH 36) were stained  with DAPI (e and h), anti-Madlp (f and i), 
and either anti-tubulin  (g) or pooled mAbs to the 90-kD component of the SPB (j). Bars, 10 Ixm. 
Hardwick  and Murray  Madlp and the Spindle Assembly Checkpoint  715 Figure 7.  The ability to modify Madlp is restricted to certain por- 
tions of the cell cycle. Wild-type (KH 34) cells were arrested with 
a-factor and then released into YPD or YPD containing 15 Ixg/ml 
benomyl. Cells  were taken  at the  times indicated  and  extracts 
were  immunoblotted  using  anti-Madlp  and  anti-Clb2p  anti- 
bodies. 
for other coiled-coil proteins, such as myosin and kinesin 
(Hackney et  al.,  1992;  Hirano  and  Mitchison,  1994).  We 
therefore  propose  that  Madlp  has  a  large  Stokes' radius 
and that  it may be  rod shaped,  consistent  with  the  elon- 
gated structure of many coiled-coil proteins. 
Modification of Madlp by Phosphorylation 
Does cell cycle progression or activation of the spindle as- 
sembly  checkpoint  alter  the  abundance  or  posttransla- 
tional modification of Madlp? To answer these questions 
we examined cells released  from a  G1  arrest into normal 
or benomyl containing medium.  Wild-type cells were  ar- 
rested in G1 with a-factor and then released into YPD or 
YPD  containing  15  p~g/ml benomyl.  Samples  were  col- 
lected over two cell cycles and analyzed for the abundance 
of Madlp  by immunoblotting.  To  monitor  the  timing  of 
the cell cycle, these blots were also probed with antibodies 
to the mitotic cyclin Clb2p which is degraded at the end of 
mitosis.  Fig.  7  shows  that  the  abundance  of Madlp  re- 
mains constant through the cell cycle and is not affected by 
benomyl-induced mitotic arrest.  During a  normal cell cy- 
cle there  is only a  minor variation  in the gel mobility of 
Madlp,  however a  significant  fraction of the protein  de- 
creases in gel mobility when cells are arrested in mitosis by 
benomyl treatment (similar results were obtained with no- 
codazole; data not shown). The low level of Madlp modi- 
fication seen  in  untreated  cells  may be  induced  by tran- 
sient  spindle  defects  that  occur in  the  course  of normal 
spindle  assembly. Figs.  9  and 10 clearly demonstrate  that 
the  slower migrating bands  are forms of Madlp  and  not 
cross-reacting proteins that accumulate in mitosis. 
The slower migrating form of Madlp appears in mitoti- 
cally arrested cells whose levels of Clb2p are high, suggest- 
ing that modification of Madlp  is a  specific response  to 
a  disrupted  spindle.  To  test  this  hypothesis  we  asked 
whether Madlp was modified when cells arrested  at Start 
with a-factor were treated with benomyl (Fig. 8 a). Half of 
the  a-factor-arrested  cells  were  treated  with  30  ixg/ml 
benomyl in the continuous presence of a-factor to prevent 
their passage through Start.  The other half were released 
from their  a-factor arrest  into YPD containing benomyl. 
Fig. 8 a  shows that benomyl treatment of cells maintained 
at the a-factor arrest point causes much less modification 
of Madlp  than  releasing  cells  from  a-factor  arrest  into 
benomyl. The low level of Madlp modification seen after 
2  h  of combined  treatment  with  a-factor  and  benomyl 
probably represents  a  fraction of the  cells that  have bro- 
ken  through  the  a-factor  arrest.  This  experiment  shows 
that the modification of Madlp is not simply a response to 
benomyl, but is seen only in cells in the portion of the cell 
cycle where spindle assembly can occur. 
To determine  whether other mitotic arrests  are accom- 
panied  by  Madlp  modification,  we  analyzed  Madlp  in 
number of other mutants. Fig. 8 b shows that the modifica- 
tion of Madlp  is not seen  in either cdc23 mutants  which 
prevent  the  ubiquitin-mediated  proteolysis  necessary  to 
initiate anaphase and thus arrest early in mitosis with short 
spindles  (Irniger et  al.,  1995),  or in cdc15 mutants  which 
arrest  later  in  mitosis  with  long  spindles  (Surana  et  al., 
1993).  This result  demonstrates  that  Madlp  modification 
Figure 8.  Madlp is not modified when 
alpha-factor arrested  cells  are  treated 
with  benomyl, or in cdc23 and  cdcl5 
mitotic arrests,  but it is in a tub2 mi- 
totic arrest.  (a) Wild-type cells (KH 34) 
were  arrested  with  a-factor and  then 
treated with 30 ~zg/ml benomyl, either 
with  or  without  releasing  them  from 
the c~-factor arrest.  The modification of 
Madlp  was  analyzed by immunoblot- 
ting.  (b)  Wild-type  (KH  34),  cdc15-2 
(KH 161), and cdc23 (KH 162) mutants 
were arrested  in G1 with  a-factor, re- 
leased, and then grown at 37°C for 2 h. 
The  modification of Madlp  was  ana- 
lyzed  by  immunoblotting.  (c)  Wild- 
type (KH 146) and tub2-403 (KH 152) 
cells were arrested in G1 with a-factor, 
released, and then grown at 15°C. Lev- 
els  and  modification  of  Clb2p  and 
Madlp were analyzed by immunoblot- 
ting. 
The Journal of Cell Biology,  Volume 131, 1995  716 requires spindle perturbations in addition to an arrest with 
high levels of Cdc28-Clb-associated kinase activity. 
To test whether other methods of disrupting spindle mi- 
crotubules  lead  to  the  modification  of Madlp,  we  com- 
pared synchronous cultures of wild-type and cold-sensitive 
tub2-403 strains (Huffaker et al.,  1988)  that had been ar- 
rested  with  a-factor and  then  released  at  15°C.  Fig.  8  c 
shows that the tub2 mutant arrests in mitosis with high lev- 
els  of Clb2p  and  that  a  significant  fraction of Madlp  is 
modified.  In addition,  we note that  Madlp is transiently 
modified in the wild-type cells, and that this occurs before 
the levels of Clb2p peak, when the spindle is presumably 
being assembled. Such modification can be seen in wild- 
type cells growing at higher temperatures (see Fig. 7) but 
is less obvious, consistent with it being a response to tem- 
perature-induced spindle perturbations (Dustin, 1984). 
Is the reduced gel mobility of Madlp due to phosphoryla- 
tion? To test this possibility we immunoprecipitated Madlp 
from logarithmically growing and benomyl-arrested cells 
and treated the immunoprecipitates with lambda protein 
phosphatase.  Fig.  9  a  shows  that  phosphatase  treatment 
eliminates the  slower migrating forms of Madlp,  consis- 
tent with the reduced mobility resulting from phosphory- 
lation. Treatment with lambda protein phosphatase in the 
presence of phosphatase inhibitors has no effect on the gel 
mobility of Madlp.  As  not  all  protein  phosphorylations 
are accompanied by a gel shift we also analyzed Madlp in 
cells that were metabolically labeled with [32p]orthophos- 
phate. Extracts were prepared from exponentially growing 
or  cell  cycle-arrested  cultures,  immunoprecipitated  with 
the polyclonal anti-Madlp antiserum, and analyzed by gel 
electrophoresis and autoradiography. Fig. 9 b  shows that 
phosphate incorporation into Madlp  occurs to equal ex- 
tents in exponentially growing, benomyl-arrested, and a-fac- 
tor-arrested  ceils,  suggesting  that  Madlp  is  phosphory- 
lated throughout the cell cycle. Our inability to see more 
slowly  migrating  phosphate  labeled  forms  of  Madlp  in 
benomyl-treated cells may reflect the relatively low level 
of labeling, or the poor mitotic arrest produced by benomyl 
treatment in low phosphate medium, or both. 
We also examined the phosphorylation of the N-termi- 
nal half of Madlp that is expressed in the madlA.1  strain. 
Although  32p  is  incorporated  into  this  fragment  as  effi- 
ciently as it is into the wild-type protein (Fig. 9), none of 
the  original mad1  alleles nor this  truncated  protein  (not 
shown) show the mobility shift that occurs when wild type 
cells are treated with benomyl (Fig.  10 a). These findings 
indicate that Madlp is the target for two types of phospho- 
rylation: constitutive phosphorylation that appears to oc- 
cur throughout the cell cycle and on both functional and 
Figure 9.  Madlp is phosphorylated. (a) Madlp was immunopre- 
cipitated from wild-type extracts made from cells (KH 34) grow- 
ing in YPD (log) or YPD with 30 ~g/ml benomyl. The indicated 
immunoprecipitates  were  treated  with  lambda  protein  phos- 
phatase, in  the  presence or  absence of phosphatase inhibitors 
(inh),  and  then  immunoblotted with  anti-Madlp.  (b)  Madlp 
was immunoprecipitated from [32p]orthophosphate-labeled  cells. 
Wild-type cells (KH 34) were grown in low phosphate YPD me- 
dium or the same medium containing either 10 p.g/ml a-factor or 
30 ~g/ml benomyl. The rnadlA.1  (KH 123), madlA.2 (KH 13I), 
and bublA (KH 127) cells were all grown in low phosphate YPD 
medium. 
Figure 10.  Hyperphosphorylation of Madlp in spindle assembly 
checkpoint mutants.  (a) Wild-type (KH 34) and the three original 
madl alleles (BEN 24, 27, and 76) were grown to log phase and 
treated with 30 ixg/ml benomyl for 3 h. Whole cell extracts were 
immunoblotted with anti-Madlp. (b) Wild-type (KH 34), madlA.1 
(KH 123), mad2-1 (KH 132), mad3A (KH 125), bublA (KH 127), 
bub2A (KH 128), and bub3A (MAY 2072) strains were grown to 
log phase, and then treated with 30 ~g/ml benomyl for 3 h. Whole 
cell extracts were made and immunoblotted with anti-Madlp. 
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rylation that is induced by activation of the spindle assem- 
bly checkpoint and occurs only on functional Madlp. 
We asked whether Madlp was hyperphosphorylated in 
mutants defective in the spindle assembly checkpoint. To 
do this we examined the gel mobility of Madlp in extracts 
made from wild type, mad, or bub strains that were grown 
in the absence or presence of 30 ixg/ml benomyl. Fig. 10 b 
shows  that  Madlp  hyper-phosphorylation was  undimin- 
ished in the mad3A and bub2A mutants, from which we 
conclude that neither Mad3p nor Bub2p are necessary for 
this modification of Madlp. However, the hyperphospho- 
rylation of Madlp  was  dramatically reduced in mad2-1, 
and absent in the bublA and bub3A mutant strains. This 
shows  that Bublp, Bub3p, and Mad2p are all important 
for  this  modification  of  Madlp.  The  observation  that 
Bublp  is  a  novel protein  kinase  (Roberts  et  al.,  1994) 
prompted us to ask whether this protein is required for all 
phosphorylation events  on  Madlp.  Madlp  is  still  phos- 
phate labeled in the bublA strain showing that Bublp is 
not required for the addition of all phosphate groups to 
Madlp (Fig. 9 b). 
Discussion 
We have cloned the MAD1  gene and shown that it en- 
codes a novel nuclear phosphoprotein that is predicted to 
form coiled-coils. Like the  previously isolated madl  al- 
leles, madlA cells are  unable to delay initiation of ana- 
phase  in  response  to microtubule depolymerization and 
thus suffer a high frequency of chromosome loss and rapid 
death upon treatment with anti-microtubule drugs. Spin- 
dle disruption is accompanied by a  Madlp phosphoryla- 
tion that reduces the mobility of the protein and this mod- 
ification requires the Bublp, Bub3p and Mad2p functions, 
but not Bub2p and Mad3p, suggesting that this phosphory- 
lation  plays  an  important  role  in  the  spindle  assembly 
checkpoint. 
Antibodies to Madlp reveal that the protein has a non- 
uniform distribution within the nucleus. All cells show a 
diffuse punctate staining and many also have a small num- 
ber of brightly staining loci. Neither staining pattern re- 
producibly  colocalizes with  nuclear  pores,  spindle-pole 
bodies or telomeres, suggesting that the Madlp may be 
found at a novel location within the nucleus. Identifying 
the Madlp-containing structures will require immunoelec- 
tron microscopy or isolating Madlp homologs from organ- 
isms with better cytology. In cell extracts Madlp is largely 
soluble, and its hydrodynamic behavior suggests that Madlp 
has an elongated shape like many other coiled-coil proteins. 
Analyzing the  gel mobility and phosphate  labeling  of 
Madlp has revealed both a constitutive level of phospho- 
rylation, seen in all stages of the cell cycle that we ana- 
lyzed, and a hyper-phosphorylation induced by spindle de- 
polymerization.  The  former phosphorylation  is  seen  in 
exponentially growing cells as well as in G1 and mitotically 
arrested cells, suggesting that it occurs throughout the cell 
cycle. We do not know the identity of the constitutive phos- 
phorylation site(s),  or  whether  their  modification plays 
any role in the spindle assembly checkpoint. The regulated 
phosphorylation reduces the gel mobility of Madlp and is 
seen only in those parts of the cell cycle in which cells are 
able to assemble a spindle. The modification is detectable 
at a low level in normally growing cells, and is much more 
pronounced  in  benomyl treated  cells  suggesting  that  it 
may  be  induced  by  activation  of  the  spindle  assembly 
checkpoint. The low level of Madlp hyperphosphorylation 
in wild type cells could either reflect full activation of the 
spindle assembly checkpoint in a small fraction of the pop- 
ulation with transient spindle defects, or weak activation 
in all cells during the course of spindle assembly. We find 
that wild-type cells growing in the cold show higher levels 
of Madlp modification, and that the tub2-403 mutant ar- 
rests  in  the  cold  in  mitosis  with  hyperphosphorylated 
Madlp, showing that Madlp modification is not solely a 
response to drug-induced spindle perturbations. In addi- 
tion  we  find  that  Madlp  receives little  modification in 
cdc23 and cdc15 mutant arrests, ruling out the possibility 
that the hyperphosphorylation of Madlp is simply a  by- 
product of any cell cycle arrest  with  active  Cdc28-Clb2 
complexes. But if cdc23 mutants are first arrested at 37°C 
and  then  treated  with  benomyl without  releasing  them 
from the arrest Madlp does become hyperphosphorylated 
(data not shown), showing that spindle disassembly at this 
metaphase-like  arrest  can  be  readily  detected  by  the 
checkpoint. 
Examining  Madlp  hyper-phosphorylation in mad  and 
bub  mutants  strengthens  the case that  this  modification 
plays  an  important  role  in  the  spindle  assembly check- 
point. There is no mobility shift in mad1-1, mad1-2, mad1- 
3, or madlA.1. This observation suggests that the proper 
function of Madlp is needed for its own modification and 
is especially significant for mad1-2,  which encodes an ap- 
parently full length protein. The modification of wild-type 
Madlp does not occur in the bubl and bub3 mutants and 
is strongly reduced in the mad2 mutant. Although the cor- 
relative evidence is strong, proof that Madlp hyperphos- 
phorylation is necessary for the spindle assembly check- 
point will require the identification and mutation of the 
regulated Madlp phosphorylation sites. 
We assume that the spindle assembly checkpoint must 
consist of at least three classes of component: a detection 
system that monitors the structure of the spindle, a signal 
transduction pathway that relays this information, and a 
target  in  the  cell cycle machinery whose regulation can 
produce a mitotic arrest. Even if the mobility shift of Madlp 
is  no more than a  correlation with the  activation of the 
spindle assembly checkpoint, it represents the first tool for 
ordering the functions in this pathway. The simplest inter- 
pretation of our data is that Madlp lies ia the middle of 
the checkpoint pathway and that mutants that fail to hy- 
perphosphorylate  this  protein  identify proteins  that  act 
upstream  of Madlp,  whereas  mutants  that  can  modify 
Madlp  identify proteins that  act  downstream  of Madlp 
(Fig.  11).  Clearly our results do not allow us to rule out 
other more complicated models. For example, Bub2p and 
Mad3p  need not  be  directly downstream  of Madlp  but 
could instead be in a parallel pathway whose action is re- 
quired  for  cell  cycle arrest  but  not  for  the  hyperphos- 
phorylation of Madlp. The isolation of dominant alleles of 
MAD1, and of the other MAD and BUB genes, that cause 
a mitotic arrest should enable us to order the function of 
these genes within the spindle assembly checkpoint more 
precisely. 
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Figure 11.  A model suggesting the order of function in the spin- 
dle assembly checkpoint. See text for details. 
Previous work identifies three candidates for the physio- 
logical Madlp kinase. The demonstration that Bublp is a 
protein kinase that can phosphorylate itself and Bub3p in 
vitro (Roberts et al., 1994), and the inability of bubl cells 
to hyperphosphorylate Madlp make Bublp a good candi- 
date for a Madlp-kinase. The MPS1 gene product is an- 
other candidate, since it has protein kinase activity in vitro 
and is required for the spindle assembly checkpoint to de- 
tect defects in spindle pole body duplication (Weiss, E., 
and M. Winey, personal communication). Finally, the ob- 
servation that  activation of the  spindle  assembly check- 
point in frog egg extracts requires the activities of MAP ki- 
nases suggests that members of this kinase family are also 
candidates for the Madlp kinase  (Minshull et al.,  1994). 
By  identifying  the  sites  of  benomyl-dependent  Madlp 
phosphorylation we hope to determine their role in the 
spindle  assembly checkpoint and  to identify the  kinases 
and phosphatases that regulate this modification. 
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